Clinical Trial Update: Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing tacrolimus to mycophenolate for autoimmune hepatitis patients with incomplete response to first-line therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• MycoPhenolate (mycophenolate mofetil)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Autoimmune Hepatitis | Phase 4 | Status: UNKNOWN